MedTrace Logo

Cost-effectiveness of EGDT Using FloTrac/EV1000

NCT05826795 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 60

Last updated 2023-04-24

No results posted yet for this study

Summary

Coronary artery bypass graft (CABG) with cardiopulmonary bypass (CPB) is a high-risk surgery with significant morbidity that results in a prolonged stay in the intensive care unit (ICU) at an increased cost. Early goal-directed therapy (EGDT) using the FloTrac/EV1000 platform improved outcomes in these patients with shorter ICU stay but with extra cost for a FloTrac transducer. The objective of this study is to assess the cost-effectiveness of implementing the FloTrac/EV1000 in these patients.

Conditions

Interventions

PROCEDURE

Early goal-directed therapy (EGDT)

The principle of hemodynamic optimization to achieve the defined goals.

Sponsors & Collaborators

  • Khon Kaen University

    lead OTHER

Principal Investigators

  • Sirirat Tribuddharat, MD, PhD · Faculty of Medicine, Khon Kaen University

Eligibility

Min Age
18 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-04-01
Primary Completion
2023-05-01
Completion
2023-05-10

Countries

  • Thailand

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05826795 on ClinicalTrials.gov